← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2016Last known activity
Jan 1, 2026
Timeline
1820s
- Jan 1, 1828
University of Central Lancashire— Founded
Drugs by trial phase (14 distinct, 12 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (23)
- NCT06901986Lead sponsorN/AJan 1, 2026
- NCT06901986Sponsor investigatorN/AJan 1, 2026
- NCT06795438Sponsor investigatorN/AFeb 1, 2025
- NCT06795438Lead sponsorN/AFeb 1, 2025
- NCT06884566Sponsor investigatorN/AJan 7, 2025
- NCT06884566Lead sponsorN/AJan 7, 2025
- NCT06230861Lead sponsorN/AMar 1, 2024
- NCT06230861Sponsor investigatorN/AMar 1, 2024
- NCT05938114Reponsible party - principal investigatorN/AJan 31, 2024
- NCT05938114Study chairN/AJan 31, 2024
- NCT05938114Lead sponsorN/AJan 31, 2024
- NCT05561543Lead sponsorN/AMar 1, 2023
- NCT05561543Reponsible party - principal investigatorN/AMar 1, 2023
- NCT05486507Lead sponsorN/AFeb 1, 2023
- NCT05486507Reponsible party - principal investigatorN/AFeb 1, 2023
Details
- Founded
- Preston, US Jan 1, 1828
- Last known activity
- Jan 1, 2026